1-19243708-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_015047.3(EMC1):c.287-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,614,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_015047.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251444Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135908
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461802Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 727208
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74362
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | May 02, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 22, 2022 | Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. ClinVar contains an entry for this variant (Variation ID: 445564). This variant has not been reported in the literature in individuals affected with EMC1-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change affects an acceptor splice site in intron 3 of the EMC1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in EMC1 are known to be pathogenic (PMID: 26572623, 26942288, 29271071). - |
Cerebellar atrophy, visual impairment, and psychomotor retardation; Pathogenic:1
Likely pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | May 02, 2023 | The heterozygous c.287-1G>A variant in EMC1 was identified by our study, in the compound heterozygous state along with a variant of uncertain significance (dbSNP ID: rs1448410617), in one individual with global developmental delay and congenital myopathy. Trio genome analysis revealed that this variant was in trans with a variant of uncertain significance (dbSNP ID: rs1448410617). The c.287-1G>A variant in EMC1 has not been previously reported in individuals with cerebellar atrophy, visual impairment, and psychomotor retardation but has been identified in 0.005% (2/41452) of African/American chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs751484278). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 445564) and has been interpreted as likely pathogenic by Children's Mercy Hospital and Clinics Center for Pediatric Genomic Medicine. This variant is located in the 3' splice region. Computational tools predict a splicing impact, though this information is not predictive enough to determine pathogenicity. A different nucleotide change that also results in a splice acceptor variant at the same site, c.287-1G>T, has been previously reported likely pathogenic in ClinVar (Variation ID: 972296), and the variant being assessed here, c.287-1G>A, is predicted by SpliceAI to have a similar effect on splicing. Loss of function of the EMC1 gene is strongly associated to autosomal recessive cerebellar atrophy, visual impairment, and psychomotor retardation. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive cerebellar atrophy, visual impairment, and psychomotor retardation. ACMG/AMP Criteria applied: PVS1_Strong, PS1_Supporting, PM2_Supporting (Richards 2015). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at